COLUMN GROUP II, LP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for COLUMN GROUP II, LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of COLUMN GROUP II, LP. COLUMN GROUP II, LP is a 10% Owner in RAPT Therapeutics, Inc. ($RAPT) and a 10% Owner in Arcus Biosciences, Inc. ($RCUS) and a 10% Owner in Gritstone Oncology, Inc. ($GRTS) and a 10% Owner in Oric Pharmaceuticals, Inc. ($ORIC).
Address: 1700 OWENS STREET, SUITE 500 SAN FRANCISCO 94158 CA
Companies in which COLUMN GROUP II, LP is an Insider
Arcus Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of COLUMN GROUP II, LP: 10% Owner
Holdings: 1,767,676 shares
Latest Transaction: Mar 19 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Gritstone bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of COLUMN GROUP II, LP: 10% Owner
Holdings: 3,102,934 shares
Latest Transaction: Oct 02 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oric Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of COLUMN GROUP II, LP: 10% Owner
Holdings: 3,575,000 shares
Latest Transaction: Apr 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RAPT Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of COLUMN GROUP II, LP: 10% Owner
Holdings: 3,835,679 shares
Latest Transaction: Sep 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of COLUMN GROUP II, LP
Sentiment: All, RCUS, GRTS, ORIC, RAPT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23 2020 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Sell | S | 30.85 | 608,000 | 18,756,800 | 3,835,679 | 4.4 M to 3.8 M (-13.68 %) |
| Sep 23 2020 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Sell | S | 30.85 | 608,000 | 18,756,800 | 3,835,679 | 4.4 M to 3.8 M (-13.68 %) |
| Aug 19 2020 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Sell | S | 22.75 | 538,654 | 12,254,379 | 4,443,679 | 5 M to 4.4 M (-10.81 %) |
| Jun 22 2020 | RAPT | RAPT Therapeutics, ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | J | 28.27 | 22,500 | 636,075 | 22,500 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 151,515 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 416,666 | 0 | 0 | |
| Apr 28 2020 | ORIC | Oric Pharmaceutica ... | COLUMN GROUP II, LP | 10% Owner | Option Exercise | C | 0.00 | 625,000 | 0 | 0 |